Metastatic bladder cancer: Advances in treatment

Keyphrases

• Gemcitabine 100%
• Cytotoxic Drugs 100%
• Metastatic Bladder Cancer 100%
• Interferon-α (IFN-α) 50%
• Response Rate 50%
• Safety Profile 50%
• Chemotherapy 50%
• Phase II Study 50%
• Paclitaxel 50%
• Bladder Cancer 50%
• Nucleoside Analogues 50%
• Methotrexate 50%
• Doxorubicin 50%
• New Agents 50%
• Cisplatin 50%
• Gallium Nitride 50%
• Vinblastine 50%
• Effects on Survival 50%
• Good Safety 50%

Pharmacology, Toxicology and Pharmaceutical Science

• Bladder Cancer 100%
• Gemcitabine 66%
• Cytotoxic Agent 66%
• Chemotherapy 33%
• Interferon 33%
• Side Effect 33%
• Paclitaxel 33%
• Cisplatin 33%
• Methotrexate 33%
• Doxorubicin 33%
• Vinblastine 33%
• Gallium Nitrate 33%
• Nucleoside Analog 33%